---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-328715"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:25:11.380252+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Minerva Neurosciences stockholders approve increase in authorized common shares to 250M and 12.5M new equity plan shares

## Summary
- Stockholders approved increasing authorized common shares from 125M to 250M. Votes: 4,917,181 for, 314,773 against.
- Approved amendment to 2013 Equity Plan adding 12,500,000 shares for issuance under the plan. Votes: 3,653,490 for, 32,045 against.
- Elected Fouzia Laghrissi-Thode and Inderjit Kaul as directors with 3,502,340 and 3,650,817 votes for, respectively.
- Approved issuance of common shares upon conversion of Series A Preferred Stock. Votes: 2,909,574 for, 114,818 against.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 5,152,013 votes for.

## SEC filing metadata
- accession: 0001193125-25-328715
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312525328715/0001193125-25-328715-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312525328715/d16725d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-328715
- JSON: https://secwatch.observer/filing/0001193125-25-328715.json
- Plain text: https://secwatch.observer/filing/0001193125-25-328715.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.